Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Clinical"

2013 ACR/ARHP Annual Meeting: Strides Made in Understanding Systemic Sclerosis

Susan Bernstein  |  February 1, 2014

Greater knowledge of how vasculitis, fibrosis, and autoimmunity interact in these destructive diseases will result in better clinical management

Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

Jonathan S. Hausmann, MD  |  January 1, 2014

Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

President’s Perspective: The ACR’s RISE Registry Will Simplify Reporting, Comparing Clinical Data

Joseph Flood, MD  |  January 1, 2014

Set to launch during first quarter 2014, the Rheumatology Informatics System for Effectiveness (RISE) database will help rheumatologists manage patient populations, improve care, advance rheumatology

ACR Research Conferences to Focus on Rheumatic Diseases

Staff  |  September 1, 2013

The ACR’s Basic Research Conference and Clinical Research Conference on October 25–26 to feature new perspectives on development of rheumatoid arthritis, lupus, and vasulitis, and review current thinking on preclinical rheumatic disease

Letters: Don’t Forget Lyme Disease When Considering Polymyalgia Rheumatica

Alfred Miller, MD and William P. Docken, MD  |  July 1, 2013

Lyme disease may present the identical clinical picture to PMR and must be ruled out

What Adult Rheumatologists Need to Know about Juvenile Arthritis

Peter A. Nigrovic, MD  |  May 1, 2013

How to recognize distinctions between pediatric and adult arthritis

Letter: Should We Monitor Asymptomatic Hyperuricemia?

William Treuhaft, MD  |  March 1, 2013

Why have physicians stopped routine screening for hyperuricemia and is there any value to this screening?

Letter: There’s No Reason Now to Screen for Uric Acid

Robert H. Shmerling, MD  |  March 1, 2013

Screening was common in the 1970s and before, but new studies demonstrate that most hyperuricemia patients never developed gout or kidney stones, so enthusiasm for screening waned

ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)

Staff  |  March 1, 2013

Widely variable results for people post-TKR procedures have prompted doctors to develop a standardized approach to rehabilitation care

ACR/ARHP Annual Meeting 2012: Physicians Find Treatment Options Limited for Scleroderma Bowel Disease

Thomas R. Collins  |  March 1, 2013

With few proven medical treatments for scleroderma bowel disease, physicians often recommend a lifestyle change for patients as a first treatment option

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences